India Globalization Capital, Inc. Stock Nyse
Equities
US45408X3089
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 1.24M | Sales 2025 * | 1.4M | Capitalization | 30.26M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -10M | EV / Sales 2024 * | 24.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 21.6 x |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-2.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.56% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Richard Prins
CHM | Chairman | 67 | 07-04-30 |
Director/Board Member | 78 | 22-01-17 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |